Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results; Issues 2022 Financial Guidance; Completes Comprehensive Strategic Review; Unveils Plan to Reshape the Company for the Future

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. NVDA
9. BLZE
10. NKE

Go back to Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results; Issues 2022 Financial Guidance; Completes Comprehensive Strategic Review; Unveils Plan to Reshape the Company for the Future

Viatris (VTRS) PT Lowered to $19 at BMO Capital

March 1, 2022 7:16 AM EST

BMO Capital analyst Gary Nachman lowered the price target on Viatris (NASDAQ: VTRS) to $19.00 (from $23.00) while maintaining an Outperform rating.

The analyst commented, "4Q was in-line, but 2022 guidance was light (though FX is factor, guidance seems conservative). Bigger focus taking stock down was Biocon... More

Viatris (VTRS) PT Lowered to $10 at Cowen

February 28, 2022 12:16 PM EST

Cowen analyst Ken Cacciatore lowered the price target on Viatris (NASDAQ: VTRS) to $10.00 (from $15.00) while maintaining a Market Perform rating following weak Q4 results and guidance, and plans to divest some franchises.

The analyst commented, "Following another weak result and 2022 guidance that... More

Viatris Inc (VTRS) Reports Q4 Adjusted Net Earnings of $971M

February 28, 2022 6:09 AM EST

Viatris Inc (NASDAQ: VTRS) reported Q4 adjusted net earnings of $971M. Revenue for the quarter came in at $4.33 billion versus the consensus estimate of $4.35 billion.

GUIDANCE:

Viatris Inc sees FY2022 revenue of $17-17.5 billion.

For earnings history and earnings-related data on Viatris Inc (VTRS) click here.

... More